why choose us

Clinical Trials Search

Showing 16,730 of 132,963 result(s)
Assessment of Trace Elements, Systemic Inflammation and Electrolytes

Status: Completed

Condition: Copd

Interventions: Interventional

Date: 2023-01-04

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Status: Active, not recruiting

Condition: Presbyopia

Interventions: Interventional

Date: 2023-01-04

Comparison of Home- vs. Gym-based Exercise Delivery Modes

Status: Completed

Condition: Vascular Stiffness
Cardiorespiratory Fitness

Interventions: Interventional

Date: 2023-01-04

Erector Spinae Plane Block for Postoperative Pain Management

Status: Completed

Condition: Pain
Post Operative Pain

Interventions: Interventional

Date: 2023-01-04

Evaluation of a Combined Ridge Expansion Technique With Simultaneous Dental Implant Placement

Status: Active, not recruiting

Condition: Alveolar Process Atrophy

Interventions: Interventional

Date: 2023-01-04

Prediction of Hypotension During Cesarean Delivery Using Positional Change of Hemodynamic Parameters

Status: Completed

Condition: Cesarean Section
Hypotension
Anesthesia, Spinal
Heart Rate
Blood Pressure

Interventions: Not Provided

Date: 2023-01-04

Effectiveness of Incentive Spirometer and Diaphragmatic Breathing Exercise on ABG Measures in Post-CABG Patients

Status: Completed

Condition: Post Coronary Artery Bypass Grafting

Interventions: Interventional

Date: 2023-01-04

microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis

Status: Completed

Condition: Erosive Osteoarthritis
Psoriatic Arthritis

Interventions: Genetic: miRNA
Assessment of miRNA, as potential biomarkers to discriminate erosive hand osteoarthritis from psoriatic arthritis

Date: 2023-01-04

Replicor Compassionate Access Program

Status:

Condition: Viral Hepatitis B
Viral Hepatitis D
Cirrhosis, Liver
Decompensated Cirrhosis
Asc

Interventions: Drug: REP 2139-Mg
REP 2139-Mg is the magnesium chelate complex of REP 2139
Drug: Tenofovir Disoproxil Fumarate
Other Name: Viread

Date: 2023-01-04

Adverse Events Related to Low Dose Atropine

Status: Active, not recruiting

Condition: Myopia, Progressive

Interventions: Drug: Atropine Sulfate
0.01%, 0.03%, or 0.05% atropine eye drops made from compounding pharmacies.

Date: 2023-01-04